The Latest Cardiac and Vascular News
REDWOOD CITY, Calif.–(BUSINESS WIRE)–New technology using deep learning and advanced algorithms to evaluate blood flow to the heart is now being used in English hospitals to fight against coronary heart disease. Coronary heart disease (CHD) is one of the leading causes of death in the UK. It is responsible for more than […]
REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc. today announced that UnitedHealthcare now covers the HeartFlow® FFRct Analysis, extending access to their 45 million beneficiaries. With this new coverage, more than 235 million people in the United States now have access to the HeartFlow Analysis — significantly advancing HeartFlow’s mission of transforming cardiovascular care. The […]
PARIS, May 22, 2018 (GLOBE NEWSWIRE) — HeartFlow, Inc. today announced new data from the PACIFIC trial showed that the HeartFlow Analysis had the highest diagnostic performance for detecting coronary artery disease (CAD), the most common form of heart disease, when compared to other commonly used non-invasive cardiac tests. Additionally, data from […]
REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc. today announced that NHS England has chosen the HeartFlow® FFRct Analysis as part of the Innovation and Technology Payment (ITP) program. The HeartFlow Analysis was chosen as a new technology to be funded by ITP through a competitive process of nearly 300 applicants. It is the only ITP […]
REDWOOD CITY, Calif.–(BUSINESS WIRE)– HeartFlow, Inc. today announced that it has entered into a collaborative research agreement with Imperial College London. The collaboration will enable experts from HeartFlow and Imperial to work side-by-side on joint projects in the areas of medical imaging and deep learning. The company’s non-invasive HeartFlow® FFRct Analysis leverages deep […]
HeartFlow Completes Series E Financing, Securing $240 Million Proceeds Will Support Commercialization of HeartFlow® FFRct Analysis, Continued Technology Innovation and Additional Clinical Studies REDWOOD CITY, Calif.–(BUSINESS WIRE)– HeartFlow. today announced the closing of its Series E financing, securing $240 million. The company will use the proceeds from this financing to ramp up commercial […]
REDWOOD CITY, Calif.–(BUSINESS WIRE)– HeartFlow today announced that Health Care Service Corporation (HCSC), which operates Blue Cross and Blue Shield plans in Illinois, Montana, New Mexico, Oklahoma and Texas, has issued a medical policy for the HeartFlow® FFRct Analysis, a first-of-its-kind non-invasive technology that helps clinicians diagnose and treat patients with suspected coronary artery disease (CAD). HCSC […]
by Ken Dropiewski, Prime-Core Executive Search (ken@prime-core.com) Med-tech company HeartFlow is using AI and machine learning to combat heart disease. It’s estimated that coronary artery disease is the root cause of nearly 9 million deaths each year. Heart disease is difficult to diagnose because the best test for it was a heart […]
HeartFlow is the newest unicorn after a new $150 million financing round The medical company is now valued at $1.4 billion. BY THEODORE SCHLEIFER@TEDDYSCHLEIFER The medical technology company HeartFlow is now valued at over $1 billion, the latest company to hit the category threshold for the most highly valued startups. HeartFlow […]
REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc. today announced that the Centers for Medicare & Medicaid Services (CMS) has finalized a New Technology Ambulatory Payment Classification (APC) for the HeartFlow® FFRct Analysis, a first-of-its-kind non-invasive technology that helps clinicians diagnose and treat patients with suspected coronary artery disease (CAD). Under the APC payment system, […]
